• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Defendants move for acquittal in Abbott-Advanced Medical Optics insider trading case

Defendants move for acquittal in Abbott-Advanced Medical Optics insider trading case

April 6, 2017 By Brad Perriello

Advanced Medical Optics, AbbottThe defendants in an insider trading case yesterday asked a federal judge in California to acquit them of all charges, arguing that the government failed to show any evidence that they traded on inside dope about Abbott‘s (NYSE:ABT) $2.8 billion acquisition of Advanced Medical Optics in 2009.

Federal prosecutors in 2014 accused ex-Advanced Medical Optics chief James Mazzo of tipping close friend and neighbor Doug DeCinces about the deal. DeCinces, a former professional baseball player for the Baltimore Orioles, allegedly passed the information on to former teammate Eddie Murray. (Murray later agreed to settle his case for $358,000 but admitted no wrongdoing.) DeCinces agreed in 2011 to pony up $2.5 million (but admitted no guilt) to settle similar charges leveled by the SEC.

After 16 days of trial ended March 31 with a continuation until tomorrow, Mazzo, DeCinces and co-defendant David Parker all argued for acquittal, according to court documents.

“This insider trading case is extraordinary – not because of the evidence that does appear in the record, but because of what does not. After 4 weeks of trial, the record includes dozens of stock trades and hundreds of telephone records, as well as emails, exhibits, and witnesses describing dinners, hockey games, golf games, barbeques, and charity events attended by defendant James V. Mazzo, defendant Douglas V. DeCinces, their wives, and various friends and family,” Mazzo argued in his acquittal motion [emphasis theirs]. “Yet after 8 years of investigation and testimony from 17 witnesses: There is no evidence of any conversation between Mr. Mazzo … and his friend and neighbor Mr. DeCinces regarding a potential transaction between AMO and Abbott – no phone calls, no emails, and no witnesses.”

“Even the government’s own summary witness admitted that the government cannot say whether Mr. Mazzo and Mr. DeCinces were on any of the alleged phone calls, let alone what was said,” DeCinces argued in his motion.

Mazzo, now global ophthalmology president at Carl Zeiss Meditec (ETR:AFX) after a 3-year run as president and CEO at AcuFocus, argued that there is “no evidence” of him “lying, cheating, or hiding anything.”

To the contrary, evidence from those who know Mr. Mazzo best suggests that he is not the sort of person who would do such a thing,” he argued, according to the documents.

“Putting aside the government’s rhetoric, there is no link between Mr. Mazzo and the trades in this case. Instead of relying on concrete evidence, the government piles unsupported inference upon unsupported inference, hoping that speculation will suffice in this criminal case. The government’s case rests on a series of unsupported assumptions: because Mr. Mazzo and Mr. DeCinces were friends and talked on occasion, Mr. Mazzo must have told Mr. DeCinces material, nonpublic information about the AMO-Abbott transaction; because Mr. DeCinces traded in AMO stock, he must have relied on inside information; because Mr. DeCinces was enthusiastic about the stock in early January, he must have known exactly what was going on within AMO. None of these inferences are supported by evidence, and none would convince a rational juror of guilt beyond a reasonable doubt,” Mazzo argued in his motion.

Filed Under: Legal News, Optical/Ophthalmic, Wall Street Beat Tagged With: Abbott, Advanced Medical Optics, Insider Trading

More recent news

  • Penumbra completes enrollment in pulmonary embolism trial
  • Zoll opens new facility in Rhode Island
  • FDA expands clearance for Inquis Medical’s Aventus thrombectomy system
  • SS Innovations completes first robotic cardiac surgery in the Americas
  • GI Windows wins FDA nod for magnet tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy